News

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
Kochi: Ernakulam govt medical college will open an adult immunisation clinic on Monday. The clinic will provide vaccines ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
South Africa is grappling with a resurgence of the H5N1 bird flu, following outbreaks on poultry farms in Tswaing and Mkhondo ...
The CDC's Advisory Committee on Immunization Practices recommended the removal of the preservative thimerosal in seasonal influenza vaccines at their meeting.
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Arcturus has made progress in cost-cutting and focusing on CF and OTC deficiency. Click here to find out the factors that ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
"This is a very clear effort to shine a light on this anti-vaccine trope: that thimerosal is somehow dangerous.” ...